Showing posts with label journal of biomedical data mining. Show all posts
Showing posts with label journal of biomedical data mining. Show all posts

Monday, 2 January 2017

DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives

Molecular structure activity studies for some Diphthamide Nano particles derivatives indicate that the conformational characteristics along with the nature and position of the substituents on the Diphthamide Nano particles derivatives ring play an important role in their biological and biochemical activities (Figure 1). Therefore, we have calculated the optimized molecular geometries of some Diphthamide Nano particles derivatives. 

data mining journals with impact factor
Calculations are carried out on the structures of these medical, medicinal and pharmaceutical Nano drugs using Hartree–Fock calculations and also Density Functional Theory (DFT) by performing HF, PM3, MM2, MM3, AM1, MP2, MP3, MP4, CCSD, CCSD(T), LDA, BVWN, BLYP and B3LYP levels of theory using the standard 31G, 6–31G*, 6–31+G*, 6–31G(3df, 3pd), 6–311G, 6–311G* and 6–311+G* basis sets of the Gaussian 09. 

Wednesday, 17 August 2016

Identifying DNA Methylation Variation Patterns to Obtain Potential Breast Cancer Biomarker Genes

Patterns of DNA methylation in human cells are crucial in regulating tumor growth and can be indicative of breast cancer susceptibility. In our research, we have pinpointed genes with significant methylation variation in the breast cancer epigenome to be used as potential novel biomarkers for breast cancer susceptibility. 


Using the statistical software package R, we compare DNA methylation sequencing data from seven normal individuals with eight breast cancer cell lines. This is done by selecting CG sites, or cytosine-guanine pairings, at which normal cell and cancer cell variation patterns fall in different ranges, and by performing upper one-tailed chi-square tests. 

Biomarker

These selected CG sites are mapped to their corresponding genes. Using the ConsensusPath Database software, we generate genetic pathways with our data to study biological relations between our selected genes and tumorigenic cellular mechanisms. Using breast cancer-related genes from the PubMeth and GeneCards databases, we have discovered 26 potential biomarker genes, which are biologically linked to genes known to be associated with breast cancer. Read More...